Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma

Author： Ramankulov Azizbek Lein Michael Kristiansen Glen Meyer Hellmuth-A. Loening Stefan Jung Klaus

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.133, Iss.9, 2007-09, pp. : 643-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma

By Du Jun

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 517-523

Springer Publishing Company

Access to resources Recommend Favorite

Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma

By Yasuda Yosuke Fujii Yasuhisa Yuasa Takeshi Kitsukawa Shinichi Urakami Shinji Yamamoto Shinya Yonese Junji Takahashi Shunji Fukui Iwao

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 877-883

Springer Publishing Company

Access to resources Recommend Favorite

HuR expression is a marker of poor prognosis in renal cell carcinoma

By Ronkainen Hanna

Tumor Biology, Vol. 32, Iss. 3, 2011-06 ,pp. : 481-487

Springer Publishing Company

Access to resources Recommend Favorite

Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 685-689

Spandidos Publications

Access to resources Recommend Favorite

Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 860-866

Spandidos Publications

Access to resources Recommend Favorite